PTO Expands the Scope of the Immunotherapy Pilot Program
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
1M ago
The PTO’s Cancer Immunotherapy Pilot Project, begun in 2016, has been deemed a success. It permitted an applicant claiming a method to treat cancer using immunotherapy to file a petition to accelerate issuance of the first Examination Report. When the … The post PTO Expands the Scope of the Immunotherapy Pilot Program appeared first on Patents4Life ..read more
Visit website
Moderna to Pfizer: “The Pandemic is Over”
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
5M ago
On August 26th, Modernatx, Inc. and Moderna US, Inc. sued Pfizer and Biontech SE,  (Case 1:22-cv-11378 [D. Mass.]) for treble damages and attorney’s fees related to the alleged direct or indirect infringement of three of Moderna’s patents with claims directed … The post Moderna to Pfizer: “The Pandemic is Over” appeared first on Patents4Life ..read more
Visit website
Tillis Bill Tries to Fix Section 101
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
6M ago
This recently introduced bill would replace section 101 with a lot of text. The commentators are all commentating, but I have yet to read whether or not the “outlaw” status of claims to diagnostic methods—led by varying interpretations of Mayo … The post Tillis Bill Tries to Fix Section 101 appeared first on Patents4Life ..read more
Visit website
CareDx v. Natera – The Broad Road to Patent Ineligibility
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
7M ago
In CareDx v Natera, Appeal No. 2022-1027, (Fed. Cir., July 18, 2022), a three judge panel of Judges Lourie, Bryson and Hughes, affirmed the district court’s finding that the claims of U. S. patent nos. 8703652, 9845497 and 10329607 are … The post CareDx v. Natera – The Broad Road to Patent Ineligibility appeared first on Patents4Life ..read more
Visit website
Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
8M ago
We are very pleased to announce that Drew Hirshfeld will be joining SLW on June 27 as a Principal. Drew has been a long-tenured employee of the United States Patent and Trademark Office (USPTO), and was named one of Managing IP’s Top 50 Most Influential People … The post Former USPTO Official Drew Hirshfeld Joins Schwegman Lundberg & Woessner as Principal appeared first on Patents4Life ..read more
Visit website
Novartis v. Accord Redux – Panel 2 Reverses Panel 1
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
8M ago
To save me a lot of typing, please read my post of January 10, 2022, summarizing the first Panel’s holding in Novartis Pharmaceutical v Accord Healthcare, Inc., 21 F.4th 1362 (Fed. Cir., 2022). The panel in that decision was Judges … The post Novartis v. Accord Redux – Panel 2 Reverses Panel 1 appeared first on Patents4Life ..read more
Visit website
The Solicitor’s Holistic Approach to the Mayo/Alice Analysis in American Axle
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
8M ago
This is not exactly breaking news, and other commentators have discussed it, but I think that the Solicitor General’s Amicus Brief urging the Supreme Court to grant cert. in American Axle v. Neapco Holdings, Appeal No. 20-891 (May 2022) contains … The post The Solicitor’s Holistic Approach to the Mayo/Alice Analysis in American Axle appeared first on Patents4Life ..read more
Visit website
Almirall v. Amneal Pharmaceuticals – Negative Limitations II
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
10M ago
This post gets a “Part II” designation because the Fed. Cir. clarified the support necessary to find a negative limitation in the prior art (Almirall LLC v. Amneal Pharmaceuticals LLC, Appeal No. 2020-2331 (Fed. Cir., March 14, 2022)). In my … The post Almirall v. Amneal Pharmaceuticals – Negative Limitations II appeared first on Patents4Life ..read more
Visit website
Intellectual Property in Russia
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Thomas Carey
11M ago
Guest Post from Thomas C. CareyChair, Business Practice Group, at Sunstein LLP The Russian war on Ukraine has resulted in a series of US sanctions and Russian countermeasures that have disrupted the coordination of patent and trademark rights … The post Intellectual Property in Russia appeared first on Patents4Life ..read more
Visit website
Qualcomm v. Apple – Pyrrhic Victory for Qaulcomm?
Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
by Warren Woessner
1y ago
So far, it’s been a slow year for jurisprudence in the life sciences, so I thought I would take a look at the somewhat quirky decision in Qualcomm, Inc. v. Apple, Inc., Appeal nos. 2020-1558, -1559 (Fed. Cir., February 1, … The post Qualcomm v. Apple – Pyrrhic Victory for Qaulcomm? appeared first on Patents4Life ..read more
Visit website

Follow Biotechnology Patent Law Blog on Feedspot

Continue with Google
OR